相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of TGF-beta/SMAD4 signaling in cancer
Ming Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Contextual determinants of TGFβ action in development, immunity and cancer
Charles J. David et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
C-terminal domain small phosphatase-like 2 promotes epithelial-to-mesenchymal transition via Snail dephosphorylation and stabilization
Yulan Zhao et al.
OPEN BIOLOGY (2018)
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
Gonzalo Recondo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
TGF-beta family co-receptor function and signaling
Joachim Nickel et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target
Michael T. Werner et al.
BLOOD (2017)
Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses
T. Liu et al.
ONCOGENE (2017)
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Toyoaki Hida et al.
LANCET (2017)
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer
Solange Peters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling
Yi Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
ALK: a tyrosine kinase target for cancer therapy
Vijaykumar R. Holla et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2017)
Understanding and targeting resistance mechanisms in NSCLC
Julia Rotow et al.
NATURE REVIEWS CANCER (2017)
STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling
G. Wang et al.
ONCOGENE (2016)
Posttranslational Regulation of Smads
Pinglong Xu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
The Discovery and Early Days of TGF-β: A Historical Perspective
Harold L. Moses et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
Masato Morikawa et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine
Ryohei Katayama et al.
CLINICAL CANCER RESEARCH (2015)
ALK inhibitors in the treatment of advanced NSCLC
Cesare Gridelli et al.
CANCER TREATMENT REVIEWS (2014)
The genetic basis of pulmonary arterial hypertension
Lijiang Ma et al.
HUMAN GENETICS (2014)
Zinc Finger Protein 451 Is a Novel Smad Corepressor in Transforming Growth Factor-β Signaling
Yili Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Danilo Maddalo et al.
NATURE (2014)
TGF-beta signaling and epithelial-mesenchymal transition in cancer progression
Yoko Katsuno et al.
CURRENT OPINION IN ONCOLOGY (2013)
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Bengt Hallberg et al.
NATURE REVIEWS CANCER (2013)
From tall to short: The role of TGFβ signaling in growth and its disorders
Carine Le Goff et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2012)
Inhibitors of the anaplastic lymphoma kinase
Luca Mologni
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Hereditary hemorrhagic telangiectasia: from molecular biology to patient care
S. Dupuis-Girod et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
To (TGF)beta or not to (TGF)beta: Fine-tuning of Smad signaling via post-translational modifications
Katharine H. Wtighton et al.
CELLULAR SIGNALLING (2008)
C-elegans anaplastic lymphoma kinase ortholog SCD-2 controls dauer formation by modulating TGF-β signaling
David J. Reiner et al.
CURRENT BIOLOGY (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Drosophila Anaplastic Lymphoma Kinase regulates Dpp signalling in the developing embryonic gut
Margret Shirinian et al.
DIFFERENTIATION (2007)
PPM1A functions as a Smad phosphatase to terminate TGFβ signaling (Publication with Expression of Concern. See vol. 166, 2016) (Publication with Expression of Concern. See vol. 165, pg. 498, 2016)
Xia Lin et al.
CELL (2006)
Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts
H Kaneki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
R Piva et al.
BLOOD (2006)
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
C Ambrogio et al.
BLOOD (2005)
Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin
C Moog-Lutz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2
M Liang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Transforming growth factor β-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation
JM Scandura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A crucial role for the Anaplastic lymphoma kinase receptor tyrosine kinase in gut development in Drosophila melanogaster
CE Lorén et al.
EMBO REPORTS (2003)
Activation of transforming growth factor-β signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4
X Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
